Introduction

4
syncytial virus (RSV) replication and morphogenesis (26) . Moreover, the expression of 75 active Rac1 is increased after hepatitis B virus replication (59).
76
African swine fever virus (ASFV) is the causative agent of a severe and highly 77 lethal hemorrhagic disease that affects domestic pigs. This large icosahedral and 78 enveloped DNA virus is the only known member of the family Asfarviridae (17). It proteins, immature and mature virions, and also abundant virus-induced membranes.
89
Microtubule motors have also been proposed to be involved in at least three other 90 events that occur in the ASFV replication cycle, namely vimentin rearrangement into a 91 cage that finally surrounds the viral factory (57), the recruitment of virus-targeted 92 membranes to the virus factory (54), and the transport of fully assembled virions to the 93 plasma membrane before their release from an infected cell by budding (36).
94
Here we explored, for the first time, the relevance of Rho GTPase subfamily 95 during ASFV infection. We found that a general inhibition of Rho GTPases leads to a 
105
Where indicated, a recombinant virus expressing viral protein p54 fused to the green 106 fluorescence protein (GFP) was used (B54GFP-2; (32)) to identify viral factories by 107 confocal microscopy. Cell infections and titrations were carried out as previously 108 described. When indicated, we used highly purified ASFV as described elsewhere (10). coverslips were mounted onto slides using Fluorsave reagent.
205
Confocal microscopy was carried out in a Leica confocal microscope TCS SP2-AOBS between CdTB treated and non-treated cells ( Figure 3C ).
278
ASFV infectivity was not affected by the down-regulation of Rho GTPases, thus raising Rac1 and Cdc42 induction was monitored by an ELISA-based assay (G-Lisa) at a range 317 of times within first hour after virus inoculation in Vero cells ( Figure 5D ) and the 318 activation of Rac1 and Cdc42 could be also determined by an established affinity 319 precipitation assay using GST-PBD followed by immunoblot analysis (Figure 5A-C) . 
